These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9854473)

  • 21. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
    Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
    Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
    Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
    J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma.
    Han SU; Lee JH; Kim WH; Cho YK; Kim MW
    World J Surg; 1999 Nov; 23(11):1176-80. PubMed ID: 10501881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.
    Shen KH; Chi CW; Lo SS; Kao HL; Lui WY; Wu CW
    Anticancer Res; 2000; 20(2B):1307-10. PubMed ID: 10810440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients.
    Beppu K; Uchiyama A; Morisaki T; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2001; 21(3C):2195-200. PubMed ID: 11501846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes of serum hepatocyte growth factor in coronary artery disease].
    Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
    J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis.
    Khan KN; Masuzaki H; Fujishita A; Kitajima M; Hiraki K; Miura S; Sekine I; Ishimaru T
    Acta Obstet Gynecol Scand; 2006; 85(4):458-66. PubMed ID: 16612709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
    Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS
    J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
    Murakami N; Koufuji K; Shirouzu K
    Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
    Gupta A; Karakiewicz PI; Roehrborn CG; Lotan Y; Zlotta AR; Shariat SF
    Clin Cancer Res; 2008 Nov; 14(22):7385-90. PubMed ID: 19010854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.